Diversified Growth Company - Medtech B USD/ LU2304352276 /
NAV2024-05-24 | Chg.+0.1900 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
89.7700USD | +0.21% | reinvestment | Equity | NS Partners ▶ |
Funds documents
Date | Document | Year | Language | Filesize |
---|---|---|---|---|
2024-05-29 | Public WebStation Live Factsheet | 2024 | English | - |
2023-06-30 | Semi-annual report | 2023 | English | 1,710.82 KB |
2023-04-28 | Prospectus | 2023 | English | 1,645.16 KB |
2023-04-28 | PRIIP Key Information Document | 2023 | English | 61.13 KB |
2022-12-31 | Account statment | 2022 | English | 2,748.60 KB |
2020-02-17 | Key Investor Information | 2020 | English | 462.64 KB |